ANN ARBOR, Mich., Oct 16, 2007 (BUSINESS WIRE) -- Aastrom Biosciences, Inc. (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences, Inc. Conference Call to Discuss the Results from the U.S. Phase I/II Severe Fracture Trial When: Monday, October 22, 2007 at 9:00 am (EDT) Where:

ANN ARBOR, Mich., Oct 16, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, announced today that it has executed definitive Purchase Agreements for the sale of approximately 11.8 million Units in a registered direct

Oct 4, 2007 (PrimeNewswire via COMTEX News Network) -- Results Presented Today At the Congress of the German Society for Stem Cell Research in Wurzburg, Germany Early Clinical Data Supporting Use of Aastrom Bone Repair Cells (Brcs) in Treatment of Osteonecrosis of the Femoral Head Also Presented

ANN ARBOR, Mich., Sep 19, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) today announced that Gerald D. Brennan, Jr., Vice President, Administrative & Financial Operations and Chief Financial Officer, will present at the UBS Global Life Sciences Conference.

ANN ARBOR, Mich., Sep 13, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) today announced that Sheldon A. Schaffer, Ph.D., Vice President, Corporate Development & Intellectual Property, will present at the Merriman Curhan Ford & Co.

ANN ARBOR, Mich., Sep 10, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a regenerative medicine company, today reported financial results for the fourth quarter and fiscal year ended June 30, 2007. The Company also reported clinical and operational

ANN ARBOR, Mich., Sep 04, 2007 (BUSINESS WIRE) -- Aastrom Biosciences, Inc. (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences, Inc. 4th Quarter Fiscal Year 2007 Investor Conference Call When: Monday, September 10, 2007 @ 4:30 pm (EDT) Where:

Adult Stem Cell Company Slated for Growth in Ann Arbor Township

Five Sites Initiated for Phase IIb Trial in U.S.

Company Achieves Multiple Clinical Milestones; Initiates Several Clinical Trials